After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that DermTech Announces Release Date for Fourth-quarter 2023 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
DMTK belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $1.33 and fluctuated between $1.3600 as its day high and $1.2705 as its day low. The current market capitalization of DermTech Inc is $45.54M. A total of 84473.0 shares were traded on the day, compared to an average of 423.48K shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, DMTK has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Sun Kevin M sold 447 shares of DMTK for 1.45 per share on Dec 11. After the transaction, the Chief Financial Officer now owns 277,499 company shares. In a previous transaction on Dec 11, Ibarra Claudia sold 331 shares at 1.45 per share. DMTK shares that Chief Operating Officer owns now total 193,547.
Among the insiders who sold shares, Ibarra Claudia disposed of 2,607 shares on Dec 08 at a per-share price of $1.41. This resulted in the Chief Operating Officer holding 193,878 shares of DMTK after the transaction. In another insider transaction, Sun Kevin M sold 4,979 shares at $1.53 per share on Dec 07. Company shares held by the Chief Financial Officer now total 277,946.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for DMTK in the last 3 months, the mean price target is $3.60 with high estimates of $4.50 and low estimates of $2.50. In terms of 52-week highs and lows, DMTK has a high of $5.59 and a low of $1.12.
As of this writing, DMTK has an earnings estimate of -$0.56 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.54 per share and a lower estimate of -$0.61. The company reported an EPS of -$0.99 in the last quarter, which was -2.10% lower than expectations of -$0.97.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. DMTK’s latest balance sheet shows that the firm has $225.33M in Cash & Short Term Investments as of fiscal 2021. There were $7.86M in debt and $12.18M in liabilities at the time. Its Book Value Per Share was $2.13, while its Total Shareholder’s Equity was $229.70M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DMTK is Buy with a score of 4.20.
